|
|
| | BRD4 Inhibitor-31 Basic information |
| Product Name: | BRD4 Inhibitor-31 | | Synonyms: | BRD4 Inhibitor-31;1-Piperidinecarboxylic acid, 4-[[4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)benzoyl]amino]-, 1,1-dimethylethyl ester | | CAS: | 1446233-35-7 | | MF: | C31H32F2N4O5 | | MW: | 578.61 | | EINECS: | | | Product Categories: | | | Mol File: | 1446233-35-7.mol |  |
| | BRD4 Inhibitor-31 Chemical Properties |
| Boiling point | 697.2±55.0 °C(predicted) | | density | 1.37±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 13.94±0.20(predicted) |
| | BRD4 Inhibitor-31 Usage And Synthesis |
| Uses | BRD4 Inhibitor-31 (Example 136) is a BRD4 inhibitor (Kis: 0.234 μM and 0.295 μM for BRD4 BD1 and BRD4 BD2 respectively). BRD4 Inhibitor-31 can be used for research of inflammatory diseases, cancer, and AIDS[1]. | | IC 50 | BD1: 0.234 μM (Ki); BD2: 0.295 μM (Ki) | | References | [1] Bromodomain inhibitors. Patent. WO2013097601 |
| | BRD4 Inhibitor-31 Preparation Products And Raw materials |
|